SUSTAINED-RELEASE LEVODOPA IN PARKINSONISM

This publication has 9 references indexed in Scilit:

• SUSTAINED-RELEASE LEVODOPA IN PARKINSONISM
  The Lancet, 1973
• Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase
  Journal of Neurology, Neurosurgery & Psychiatry, 1973
• Immunologic Significance of In Vitro Lymphocyte Responses
  Medical Clinics of North America, 1972
• A method for the determination of dopa and 3-O-methyldopa in the plasma of parkinsonian patients
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1972
• PRIMARY IMMUNODEFICIENCIES
  Pediatrics, 1971
• Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer
  Cancer, 1971
• Demonstration of cell‐mediated immunity to human neoplasms of various histological types
  International Journal of Cancer, 1971
• LYMPHOCYTE RESPONSE TO P.H.A. IN PATIENTS WITH NON-LYMPHOID TUMOURS
  The Lancet, 1970
• Immunologic Response in Patients with Disseminated Cancer
  Annals of Surgery, 1968